Antibody Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Pregnant Woman and Transplacental Passage Into Cord Blood.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- COVID-19 Spike Protein IgG Quantitative Antibody (CMIA) Level
研究概览
简要总结
The goal of this study is to study the correlation of maternal and cord blood level of Anti SAR-CoV.
详细描述
The goal of this study is to study the correlation of maternal and cord blood level of Anti SAR-CoV. Sample size is 40 Thai patients at labor room Vachira Phuket Hospital in October - November 2023, who have at least one COVID-19 vaccination before or when pregnant. The Secondary outcome is to study time effect after COVID-19 vaccination and effect of vaccine type on Antibody level.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Thai term pregnant women
- •18-45 year old
- •At least 1 covid vaccination received
- •admission at Vachira Phuket Hospital Labor Room
排除标准
- •Do not want to participate
- •Unstable or Emergency condition
研究组 & 干预措施
Thai term pregnant woman who have at least One dose of Covid vaccination
Maternal and cord blood was collected to test COVID-19 Spike Protein IgG Quantitative Antibody (CMIA)
干预措施: COVID-19 Spike Protein IgG Quantitative Antibody (CMIA) (Diagnostic Test)
结局指标
主要结局
COVID-19 Spike Protein IgG Quantitative Antibody (CMIA) Level
时间窗: 1 month
Test for correlation of level in maternal and cord blood
次要结局
- Analysed time effect from last vaccination and type.(1 month)